Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CNS and respiratory start-up Cerecor completes $22.5mm Series A round

Executive Summary

Cerecor Inc. (drug candidates that act primarily in the brain) has completed a $22.5mm Series A financing. Maxim Group was the placement agent. According to the Form D filing, 156 investors participated, including company board members. The initial offering amount for the round was $15mm, but back in May 2011 Cerecor was targeting $30mm.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies